Failure of a protein synthesis inhibitor to modify glutamate receptor-mediated neurotoxicity in vivo

C. Leppin, F. Finiels-Marlier, Jacqueline Crawley, P. Montpied, S. M. Paul

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The delayed neuronal death (DND) resulting from brief forebrain ischemia has recently been reported to be markedly attenuated by parenteral administration of the reversible protein synthesis inhibitor, anisomycin. Previous work suggests that ischemia-induced DND is mediated by glutamate acting at one or more glutamate receptors, since glutamate receptor antagonists have been reported to reduce ischemia-induced DND. Consequently, we tested whether anisomycin could modify DND induced by direct intracerebral administration of the excitotoxins, N-methyl-d-aspartate (NMDA), α-amino-3-hydroxy-5-methylisoxasole (AMPA) or kainic acid. Anisomycin, administered parenterally, in multiple doses did not alter DND induced by any of these excitotoxins, not did combined parenteral and direct intracerebral injection of anisomycin protect against DND induced by AMPA. Thus, neurotoxicity induced by direct intracerebral administration of NMDA, AMPA or kainic acid does not appear to require de novo protein synthesis, and, therefore is not likely to be mediated by the expression of a programmed cell death cascade.

Original languageEnglish (US)
Pages (from-to)168-170
Number of pages3
JournalBrain Research
Volume581
Issue number1
DOIs
StatePublished - May 22 1992
Externally publishedYes

Fingerprint

Protein Synthesis Inhibitors
Glutamate Receptors
Anisomycin
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
Ischemia
Kainic Acid
Neurotoxins
Aspartic Acid
Excitatory Amino Acid Antagonists
Prosencephalon
Glutamic Acid
Cell Death
Injections
Proteins

Keywords

  • Excitotoxicity
  • Glutamate receptor
  • Protein synthesis inhibitor

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Failure of a protein synthesis inhibitor to modify glutamate receptor-mediated neurotoxicity in vivo. / Leppin, C.; Finiels-Marlier, F.; Crawley, Jacqueline; Montpied, P.; Paul, S. M.

In: Brain Research, Vol. 581, No. 1, 22.05.1992, p. 168-170.

Research output: Contribution to journalArticle

Leppin, C. ; Finiels-Marlier, F. ; Crawley, Jacqueline ; Montpied, P. ; Paul, S. M. / Failure of a protein synthesis inhibitor to modify glutamate receptor-mediated neurotoxicity in vivo. In: Brain Research. 1992 ; Vol. 581, No. 1. pp. 168-170.
@article{360bdd2050f74a22bc70abb5681653fa,
title = "Failure of a protein synthesis inhibitor to modify glutamate receptor-mediated neurotoxicity in vivo",
abstract = "The delayed neuronal death (DND) resulting from brief forebrain ischemia has recently been reported to be markedly attenuated by parenteral administration of the reversible protein synthesis inhibitor, anisomycin. Previous work suggests that ischemia-induced DND is mediated by glutamate acting at one or more glutamate receptors, since glutamate receptor antagonists have been reported to reduce ischemia-induced DND. Consequently, we tested whether anisomycin could modify DND induced by direct intracerebral administration of the excitotoxins, N-methyl-d-aspartate (NMDA), α-amino-3-hydroxy-5-methylisoxasole (AMPA) or kainic acid. Anisomycin, administered parenterally, in multiple doses did not alter DND induced by any of these excitotoxins, not did combined parenteral and direct intracerebral injection of anisomycin protect against DND induced by AMPA. Thus, neurotoxicity induced by direct intracerebral administration of NMDA, AMPA or kainic acid does not appear to require de novo protein synthesis, and, therefore is not likely to be mediated by the expression of a programmed cell death cascade.",
keywords = "Excitotoxicity, Glutamate receptor, Protein synthesis inhibitor",
author = "C. Leppin and F. Finiels-Marlier and Jacqueline Crawley and P. Montpied and Paul, {S. M.}",
year = "1992",
month = "5",
day = "22",
doi = "10.1016/0006-8993(92)90359-H",
language = "English (US)",
volume = "581",
pages = "168--170",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Failure of a protein synthesis inhibitor to modify glutamate receptor-mediated neurotoxicity in vivo

AU - Leppin, C.

AU - Finiels-Marlier, F.

AU - Crawley, Jacqueline

AU - Montpied, P.

AU - Paul, S. M.

PY - 1992/5/22

Y1 - 1992/5/22

N2 - The delayed neuronal death (DND) resulting from brief forebrain ischemia has recently been reported to be markedly attenuated by parenteral administration of the reversible protein synthesis inhibitor, anisomycin. Previous work suggests that ischemia-induced DND is mediated by glutamate acting at one or more glutamate receptors, since glutamate receptor antagonists have been reported to reduce ischemia-induced DND. Consequently, we tested whether anisomycin could modify DND induced by direct intracerebral administration of the excitotoxins, N-methyl-d-aspartate (NMDA), α-amino-3-hydroxy-5-methylisoxasole (AMPA) or kainic acid. Anisomycin, administered parenterally, in multiple doses did not alter DND induced by any of these excitotoxins, not did combined parenteral and direct intracerebral injection of anisomycin protect against DND induced by AMPA. Thus, neurotoxicity induced by direct intracerebral administration of NMDA, AMPA or kainic acid does not appear to require de novo protein synthesis, and, therefore is not likely to be mediated by the expression of a programmed cell death cascade.

AB - The delayed neuronal death (DND) resulting from brief forebrain ischemia has recently been reported to be markedly attenuated by parenteral administration of the reversible protein synthesis inhibitor, anisomycin. Previous work suggests that ischemia-induced DND is mediated by glutamate acting at one or more glutamate receptors, since glutamate receptor antagonists have been reported to reduce ischemia-induced DND. Consequently, we tested whether anisomycin could modify DND induced by direct intracerebral administration of the excitotoxins, N-methyl-d-aspartate (NMDA), α-amino-3-hydroxy-5-methylisoxasole (AMPA) or kainic acid. Anisomycin, administered parenterally, in multiple doses did not alter DND induced by any of these excitotoxins, not did combined parenteral and direct intracerebral injection of anisomycin protect against DND induced by AMPA. Thus, neurotoxicity induced by direct intracerebral administration of NMDA, AMPA or kainic acid does not appear to require de novo protein synthesis, and, therefore is not likely to be mediated by the expression of a programmed cell death cascade.

KW - Excitotoxicity

KW - Glutamate receptor

KW - Protein synthesis inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0026654647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026654647&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(92)90359-H

DO - 10.1016/0006-8993(92)90359-H

M3 - Article

C2 - 1379868

AN - SCOPUS:0026654647

VL - 581

SP - 168

EP - 170

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -